Table 5.
Added Value of Human Immunodeficiency Virus–Related Disease Severity and NAT2 Acetylator Status
| Metric | Antiretroviral Therapy Experienced | CD4 <200 | Viral Load ≥200 | NAT2 |
|---|---|---|---|---|
| LR test P value | .03 | .81 | .47 | .88 |
| Net reclassification index | 0.24 | <0.01 | 0.16 | 0.13 |
| Integrated discrimination improvement | 0.01 | <0.01 | <0.01 | <0.01 |
| Fraction of new information based on comparison of model LRs | 0.03 | <0.01 | <0.01 | <0.01 |
| Fraction of new information based on ratio of the variances explained by the models | 0.03 | <0.01 | <0.01 | <0.01 |
| Fraction of new information based on variance of predicted risk to the sum of the variance of predicted risk and the average risk | 0.03 | <0.01 | <0.01 | <0.01 |
Abbreviation: LR, likelihood ratio.